Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4 | $16 | $27 | $41 |
| - Cash | $10 | $9 | $12 | $16 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | -$4 | $9 | $17 | $27 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -69.7% | -7.9% | -45.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32.6% | -69.1% | -84.2% | -27.4% |
| EBITDA | -$3 | -$3 | -$4 | -$4 |
| % Margin | -6,884.8% | -2,250% | -2,489.1% | -1,371.9% |
| Net Income | -$10 | -$3 | -$6 | -$9 |
| % Margin | -22,417.4% | -2,255.9% | -3,511.5% | -3,027.1% |
| EPS Diluted | -1.75 | -0.58 | -0.98 | -1.58 |
| % Growth | -201.7% | 40.8% | 38% | – |
| Operating Cash Flow | -$3 | -$2 | -$4 | -$4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$3 | -$4 | -$4 |